RBF Capital’s Pfizer PFE Stock Holding History

RBF Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,810	Closed	-$467K	–	308
2014 Q4	$467K	Buy	+15,810	New	+$453K	0.1%	169

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RBF Capital's PFE Position: Q1 2015 in Review

RBF Capital sold out of Pfizer (PFE) in Q1 2015, closing a stake of 15,810 shares — an estimated $467K sold.

RBF Capital first reported a position in PFE in Q4 2014 and held it in 1 quarter. The position peaked at $467K in Q4 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

RBF Capital reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
RBF Capital sold 15,810 Pfizer shares in Q1 2015, an estimated $467K.
RBF Capital first reported a position in Pfizer in Q4 2014 and held it in 1 quarter.
RBF Capital's Pfizer position peaked at $467K in Q4 2014.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on RBF Capital's 13F filing for Q1 2015, filed 14 May 2015.